Search research articles
Contact Us
Filters
Showing results (101-110 of 109) with videos related to
Page
of 11
Sort By:
You have reached the last page of results.
This site can display upto 109 results.
Cancers
|
April 3, 2021
Clinical Features and Multiplatform Molecular Analysis Assist in Understanding Patient Response to Anti-PD-1/PD-L1 in Renal Cell Carcinoma
Eileen Shiuan, Anupama Reddy, Stephanie O Dudzinski, et al.
Cell
|
April 7, 2018
Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics
Li Ding, Matthew H Bailey, Eduard Porta-Pardo, et al.
The Journal of Clinical Investigation
|
June 14, 2016
Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality
Asim Saha, Roddy S O'Connor, Govindarajan Thangavelu, et al.
Journal of Translational Medicine
|
February 21, 2024
A community challenge to predict clinical outcomes after immune checkpoint blockade in non-small cell lung cancer
Mike Mason, Óscar Lapuente-Santana, Anni S Halkola, et al.
Cell Reports
|
June 21, 2018
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma
Christopher J Ricketts, Aguirre A De Cubas, Huihui Fan, et al.
Cell Reports
|
April 5, 2024
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma
Christopher J Ricketts, Aguirre A De Cubas, Huihui Fan, et al.
Cell Reports
|
April 5, 2018
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma
Christopher J Ricketts, Aguirre A De Cubas, Huihui Fan, et al.
Immunity
|
August 22, 2019
The Immune Landscape of Cancer
Vésteinn Thorsson, David L Gibbs, Scott D Brown, et al.
Immunity
|
April 10, 2018
The Immune Landscape of Cancer
Vésteinn Thorsson, David L Gibbs, Scott D Brown, et al.
Page
of 11
Search research articles
Search
Showing results (101-110 of 109) with videos related to
Sort By:
Page
of 11
You have reached the last page of results.
This site can display upto 109 results.
Cancers
|
April 3, 2021
Clinical Features and Multiplatform Molecular Analysis Assist in Understanding Patient Response to Anti-PD-1/PD-L1 in Renal Cell Carcinoma
Eileen Shiuan, Anupama Reddy, Stephanie O Dudzinski, et al.
Cell
|
April 7, 2018
Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics
Li Ding, Matthew H Bailey, Eduard Porta-Pardo, et al.
The Journal of Clinical Investigation
|
June 14, 2016
Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality
Asim Saha, Roddy S O'Connor, Govindarajan Thangavelu, et al.
Journal of Translational Medicine
|
February 21, 2024
A community challenge to predict clinical outcomes after immune checkpoint blockade in non-small cell lung cancer
Mike Mason, Óscar Lapuente-Santana, Anni S Halkola, et al.
Cell Reports
|
June 21, 2018
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma
Christopher J Ricketts, Aguirre A De Cubas, Huihui Fan, et al.
Cell Reports
|
April 5, 2024
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma
Christopher J Ricketts, Aguirre A De Cubas, Huihui Fan, et al.
Cell Reports
|
April 5, 2018
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma
Christopher J Ricketts, Aguirre A De Cubas, Huihui Fan, et al.
Immunity
|
August 22, 2019
The Immune Landscape of Cancer
Vésteinn Thorsson, David L Gibbs, Scott D Brown, et al.
Immunity
|
April 10, 2018
The Immune Landscape of Cancer
Vésteinn Thorsson, David L Gibbs, Scott D Brown, et al.
Page
of 11